MyAverix Finance
US · Healthcare
Satellos Bioscience Inc. Common Stock (MSLE)
Biotechnology
Satellos Bioscience Inc. Common Stock (MSLE) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MSLE
Satellos Bioscience Inc. Common Stock (MSLE) — FAQ
What is MSLE's P/E ratio?
The price-to-earnings (P/E) ratio for Satellos Bioscience Inc. Common Stock (MSLE) is 25.00 (data as of 2026-05-23).
Does Satellos Bioscience Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Satellos Bioscience Inc. Common Stock (MSLE). Check the MyAverix Finance app for the latest dividend data.
What sector is Satellos Bioscience Inc. Common Stock in?
Satellos Bioscience Inc. Common Stock (MSLE) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MSLE listed on?
MSLE is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.